Merck (MRK) Dividends payables (2009 - 2026)

Merck (MRK) has reported Dividends payables for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Dividends payables rose 3.75% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 3.75% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 2.69% from the prior year.
• Dividends payables was $2.1 billion for Q2 2026 at Merck, down from $2.1 billion in the prior quarter.
• Over five years, Dividends payables peaked at $2.1 billion in Q1 2026 and troughed at $1.8 billion in Q2 2022.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Dividends payables.
• Across the five-year window, Dividends payables gained 7.68% in 2023 and grew 2.69% in 2025, its largest moves.
• Over 5 years, Dividends payables stood at $1.9 billion in 2022, then grew by 5.36% to $2.0 billion in 2023, then climbed by 4.99% to $2.1 billion in 2024, then climbed by 2.69% to $2.1 billion in 2025, then decreased by 0.47% to $2.1 billion in 2026.
• The last three Dividends payables figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.